![Pat O’Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Pat O’Sullivan worked at Genzyme Therapeutics Ltd. from 2001 to 2022 as Vice President-Global Supply Chain.
From 2022 to 2026, Mr. O’Sullivan worked at Amicus Therapeutics, Inc. as Chief Technical Operations Officer.
Mr. O’Sullivan completed an MBA at The Open University and an undergraduate degree at Munster Technological University.
Antiguos cargos conocidos de Pat O’Sullivan.
| Empresas | Cargo | Fin |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Director de Operaciones | 27/04/2026 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | 01/08/2022 |
Formación de Pat O’Sullivan.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
28
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
The Open University
 The Open University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Munster Technological University
 Munster Technological University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- Pat O’Sullivan
